Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Munk, Mathias ^a   Memon, Ashfaque Ahmed ^a   Goetze, Jens Peter ^b   Nielsen, Lars Bo ^b,c   Nexo, Ebba ^a   Sorensen, Boe Sandahl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; NEU DIFFERENTIATION FACTOR ALPHA; NEU DIFFERENTIATION FACTOR BETA; OXYGEN; TRASTUZUMAB; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART DEVELOPMENT; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BIOPSY; CELL HYPOXIA; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CORONARY ARTERY BYPASS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; MYOCYTES, CARDIAC; NERVE GROWTH FACTORS; NEUREGULIN-1; ORGAN SPECIFICITY; PROTEIN ISOFORMS; PROTEIN TRANSPORT; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SUS SCROFA;

EID: 84863616362     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040243     Document Type: Article

References (35)

1. Lee KF, Simon H, Chen H, Bates B, Hung MC, et al. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378: 394-398.
2. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, et al. (1995) Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378: 390-394.
3. Iwamoto R, Yamazaki S, Asakura M, Takashima S, Hasuwa H, et al. (2003) Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc Natl Acad Sci U S A 100: 3221-3226 10.1073/pnas.0537588100 [doi];0537588100 [pii].
4. Meyer D, Birchmeier C, (1995) Multiple essential functions of neuregulin in development. Nature 378: 386-390 10.1038/378386a0 [doi].
5. Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, et al. (2007) Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 25: 3859-3865.
6. Smith I, Procter M, Gelber RD, Guillaume S, Feyereislova A, et al. (2007) 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial. Lancet 369: 29-36.
7. Crone SA, Zhao YY, Fan L, Gu Y, Minamisawa S, et al. (2002) ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat Med 8: 459-465.
8. Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, et al. (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783-792.
9. Yarden Y, Sliwkowski MX, (2001) Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127-137.
10. Tao RH, Maruyama IN, (2008) All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells. J Cell Sci 121: 3207-3217.
11. Bersell K, Arab S, Haring B, Kuhn B, (2009) Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138: 257-270.
12. Grant S, Qiao L, Dent P, (2002) Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. Front Biosci 7: d376-d389.
13. Roux PP, Blenis J, (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-344.
14. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J, (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem 274: 32631-32637.
15. Tennant DA, Frezza C, Mackenzie ED, Nguyen QD, Zheng L, et al. (2009) Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene 45: 4009-4021.
16. Song G, Ouyang G, Bao S, (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59-71.
17. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605.
18. Aki T, Mizukami Y, Oka Y, Yamaguchi K, Uemura K, et al. (2001) Phosphoinositide 3-kinase accelerates necrotic cell death during hypoxia. Biochem J 358: 481-487.
19. Jiang Z, Zhang Y, Chen X, Lam PY, Yang H, et al. (2002) Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochem Biophys Res Commun 294: 726-733.
20. Favara BE, Franciosi RA, (1972) Diphtherial myocardiopathy. Am J Cardiol 30: 423-426.
21. Tanaka N, Masamura K, Yoshida M, Kato M, Kawai Y, et al. (2002) A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction. Biochem Biophys Res Commun 297: 375-381.
22. Iwabu A, Murakami T, Kusachi S, Nakamura K, Takemoto S, et al. (2002) Concomitant expression of heparin-binding epidermal growth factor-like growth factor mRNA and basic fibroblast growth factor mRNA in myocardial infarction in rats. Basic Res Cardiol 97: 214-222.
23. Ushikoshi H, Takahashi T, Chen X, Khai NC, Esaki M, et al. (2005) Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes. Lab Invest 85: 862-873.
24. Liu X, Gu X, Li Z, Li X, Li H, et al. (2006) Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol 48: 1438-1447.
25. Nielsen LB, Perko M, Arendrup H, Andersen CB, (2002) Microsomal triglyceride transfer protein gene expression and triglyceride accumulation in hypoxic human hearts. Arterioscler Thromb Vasc Biol 22: 1489-1494.
26. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, et al. (1998) HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 95: 2979-2984.
27. Andersen CL, Jensen JL, Orntoft TF, (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245-5250.
28. Schooler K, Wiley HS (2000) Ratiometric assay of epidermal growth factor receptor tyrosine kinase activation. Anal Biochem 277: 135-142.
29. Elenius K, Corfas G, Paul S, Choi CJ, Rio C, et al. (1997) A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem 272: 26761-26768.
30. Pouyssegur J, Lenormand P, (2003) Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Eur J Biochem 270: 3291-3299. 3707 [pii].
31. Lee KF, Simon H, Chen H, Bates B, Hung MC, et al. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378: 394-398 10.1038/378394a0 [doi].
32. Downward J, (2004) PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15: 177-182.
33. Mebratu Y, Tesfaigzi Y, (2009) How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle 8: 1168-1175.
34. Rohrbach S, Niemann B, Silber RE, Holtz J, (2005) Neuregulin receptors erbB2 and erbB4 in failing human myocardium - depressed expression and attenuated activation. Basic Res Cardiol 100: 240-249.
35. Ky B, Kimmel SE, Safa RN, Putt ME, Sweitzer NK, et al. (2009) Neuregulin-1 beta is associated with disease severity and adverse outcomes in chronic heart failure. Circulation 120: 310-317.